Synthesis and study of the anticancer activity of some new 7H-[1,2,4]triazolo [3,4-b][1,3,4]thiadiazines
DOI:
https://doi.org/10.14739/2409-2932.2021.3.240361Keywords:
organic synthesis, NMR spectroscopy, triazolo[3,4-b][1,3,4]thiadiazines, anticancer activityAbstract
The problem of finding effective low-toxic anticancer agents is one of the most important in modern medicine and pharmacy. Despite a large selection of anticancer drugs and a variety of mechanisms of their action, the effectiveness of existing drugs continues to be insufficient. Among the numerous natural and synthetic heterocyclic compounds that exhibit anticancer activity, 7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine derivatives, which are able to initiate different pathways of tumor cell death. Based on this, the synthesis of new derivatives of this class of compounds and the study of their anticancer properties is relevant.
The aim of the work is to synthesis of new 7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and study their anticancer activity.
Materials and methods. It was used methods of organic synthesis, physical and chemical methods of analysis organic compounds (1H NMR spectroscopy, elemental analysis).
Results. In order to obtain new 7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines, the interaction implemented of 4-amino-4H-[1,2,4]triazole-3-thiols with the corresponding bromoacetophenones. The reaction proceeds by heating the above reagents in alcohol with the closure of the thiadiazine ring and the formation of 7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine systems. The structure of all synthesized compounds was confirmed by 1H NMR spectroscopy and elemental analysis data.
The study of the anticancer activity of the synthesized compounds was carried out in the framework of the international scientific program DTP (Developmental Therapeutics Program) of the National Cancer Institute (NCI, Bethesda, Maryland, USA). It was found that the synthesized compounds exhibited different levels of anticancer activity. The most active among the tested substances was compound 3j with an average GP value of 28.73. The most sensitive to it were the lines of melanoma MDA-MB-435 and SK-MEL-2, kidney cancer A498 and RXF 393, CNS cancer SNB-75, and non-small cell lung cancer NCI-H522. The secondary stage of studies of this compound confirmed its high anticancer activity against most cancer cell lines.
Conclusions. As a result of the interaction of 4-amino-4H-[1,2,4]triazole-3-thiols with the relevant bromoacetophenones, a series of new triazolo[3,4-b][1,3,4]thiadiazines was not described in the literature was synthesized. Testing the synthesized compounds for the antitumor activity made it possible to isolate 1 highly active compound with a pronounced anticancer effect, which in terms of activity approaches or exceeds the known drugs 5-fluorouracil (5-FU) and cisplatin, as well as an anticancer agent, curcumin.
References
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer journal for clinicians, 71(3), 209-249. https://doi.org/10.3322/caac.21660
Schirrmacher V. (2019). From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review). International journal of oncology, 54(2), 407-419. https://doi.org/10.3892/ijo.2018.4661
Al-Mulla, A. (2017). A Review: Biological Importance of Heterocyclic Compounds. Der Pharma Chemica, 9(13), 141-147.
Kerru, N., Gummidi, L., Maddila, S., Gangu, K. K., & Jonnalagadda, S. B. (2020). A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications. Molecules, 25(8), 1909. https://doi.org/10.3390/molecules25081909
Ismail, M. I., Mohamady, S., Samir, N., & Abouzid, K. (2020). Design, Synthesis, and Biological Evaluation of Novel 7H-[1,2,4]Triazolo[3,4-b][1,3,4]thiadiazine Inhibitors as Antitumor Agents. ACS omega, 5(32), 20170-20186. https://doi.org/10.1021/acsomega.0c01829
Tardito, S., Bussolati, O., Maffini, M., Tegoni, M., Giannetto, M., Dall'asta, V., Franchi-Gazzola, R., Lanfranchi, M., Pellinghelli, M. A., Mucchino, C., Mori, G., & Marchio, L. (2007). Thioamido coordination in a thioxo-1,2,4-triazole copper(II) complex enhances nonapoptotic programmed cell death associated with copper accumulation and oxidative stress in human cancer cells. Journal of medicinal chemistry, 50(8), 1916-1924. https://doi.org/10.1021/jm061174f
Kamel, M. M., & Megally Abdo, N. Y. (2014). Synthesis of novel 1,2,4-triazoles, triazolothiadiazines and triazolothiadiazoles as potential anticancer agents. European journal of medicinal chemistry, 86, 75-80. https://doi.org/10.1016/j.ejmech.2014.08.047
Mohamady, S., Gibriel, A. A., Ahmed, M. S., Hendy, M. S., & Naguib, B. H. (2020). Design and novel synthetic approach supported with molecular docking and biological evidence for naphthoquinone-hydrazinotriazolothiadiazine analogs as potential anticancer inhibiting topoisomerase-IIB. Bioorganic chemistry, 96, 103641. https://doi.org/10.1016/j.bioorg.2020.103641
Bhatia, R., Rathore, P., & Nayak, S. (2012). Synthesis, characterization and anti-inflammatory activity of 1,2,4 triazole derivatives. Current Research in Pharmaceutical Sciences, 2(3), 160-165.
Song, M.-X., Zhang, C.-B., Deng, X.-Q., Sun, Z.-G., & Quan, Z.-S. (2011). Synthesis and anticonvulsant activity evaluation of 6-phenyl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines. Letters in Drug Design & Discovery, 8(8), 769-773. https://doi.org/10.2174/157018011796575962
Prakash, O., Aneja, D. K., Hussain, K., Lohan, P., Ranjan, P., Arora, S., Sharma, C., & Aneja, K. R. (2011). Synthesis and biological evaluation of dihydroindeno and indeno [1,2-e] [1,2,4]triazolo [3,4-b] [1,3,4]thiadiazines as antimicrobial agents. European journal of medicinal chemistry, 46(10), 5065-5073. https://doi.org/10.1016/j.ejmech.2011.08.019
Pundeer, R., Kiran, V., Prakash, R., Subhash, S., Bhatia, C., Sharma, C. & Aneja, K. α,α-Dibromoacetophenones mediated synthesis of some new 7H-7-alkoxy-3-alkyl/phenyl-6-aryl-s-triazolo[3,4-b][1,3,4]thiadiazines and their antimicrobial evaluation. Medicinal Chemistry Research, 21(12), 4043-4052. https://doi.org/10.1007/s00044-011-9945-1
Nayak, S. G., & Poojary, B. (2020). Design, synthesis, in silico docking studies, and antibacterial activity of some thiadiazines and 1,2,4-triazole-3-thiones bearing pyrazole moiety. Russian Journal of Bioorganic Chemistry, 46(1), 97-106. https://doi.org/10.1134/S1068162020010069
Myrko, I. I., Chaban ,T. I., Ogurtsov, V. V., & Matiychuk, V. S. (2021). Syntez ta doslidzhennia antymikrobnoi aktyvnosti deiakykh pirazolzamishchenykh 7H-[1,2,4]tryazolo[3,4-b][1,3,4]tiadiazyniv [Synthesis and study of antimicrobial activity of some pyrazole-substituted 7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines]. Farmatsevtychnyy chasopys, (1), 5-13. [in Ukrainian]. https://doi.org/10.11603/2312-0967.2021.1.11986
Li, Z., Bai, X., Deng, Q., Zhang, G., Zhou, L., Liu, Y., Wang, J. & Wang, Y. (2017). Preliminary SAR and biological evaluation of antitubercular triazolothiadiazine derivatives against drug-susceptible and drug-resistant Mtb strains. Bioorganic & Medicinal Chemistry, 25(1), 213-220. https://doi.org/10.1016/j.bmc.2016.10.027
Niranjan, K., Kumar, N. & Kumar, A. (2015). Synthesis of triazolothiadiazine derivatives as antioxidant agents. Journal of Pharmacy and Pharmaceutical Sciences, 7(6), 120-123.
Chaban, T. I., Ohurtsov, V. V., Matiichuk, V. S., Honcharenko, O. V., & Chaban I. H. (2019). Syntez deiakykh novykh N3 zamishchenykh 5-hidroksy-7-metyl-3H-tiazolo[4,5-b]pirydyn-2-oniv yak potentsiinykh biolohichno aktyvnykh rechovyn [Synthesis of some new N3 substituted 5-hydroxy-7-methyl-3H-thiazolo[4,5-b]pyridin-2-ones as potential biologically active substances]. Current issues in pharmacy and medicine: science and practice, 12(2), 129-134. [in Ukrainian]. https://doi.org/10.14739/2409-2932.2019.2.170974
Myrko, I., Chaban, T., Matiichuk, Y., Arshad, M. & Matiychuk, V. (2021). Approaches for the synthesis, chemical modification and biological properties of n-acylphenothiazines. Current Chemistry Letters, 10(4), 377-392. https://doi.org/10.5267/j.ccl.2021.5.005
Chaban, T. I., Matiichuk, Y. E., Shyyka, O. Y., Chaban, I. G., Ogurtsov, V. V., Nektegayev, I. A., & Matiychuk, V. S. (2020). Synthesis, Molecular Docking and Biological Properties of Novel Thiazolo[4,5-b]pyridine Derivatives. Acta chimica Slovenica, 67(4), 1035-1043. http://dx.doi.org/10.17344/acsi.2019.5439
Chaban, T., Matiichuk, Y., Сhulovska, Z., Tymoshuk, O., Chaban, I. & Matiychuk, V. (2021) Synthesis and biological evaluation of new 4-oxo-thiazolidin-2-ylidene derivatives as antimicrobial agents. Archiv der pharmazie, 354(7), e2100037. https://doi.org/10.1002/ardp.202100037
Mndjoyan A. L. (1960). Syntezy heterotsyklycheskykh soedynenyi. Vypusk 5. [Synthesis of heterocyclic compounds (Vol. 5)]. Erevan: AN ArmSSR. [in Russian].
Developmental Therapeutics Program. Available online: http://dtp.nci.nih.gov
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
